250 related articles for article (PubMed ID: 33333352)
1. Beyond antibacterials - exploring bacteriophages as antivirulence agents.
Shen Y; Loessner MJ
Curr Opin Biotechnol; 2021 Apr; 68():166-173. PubMed ID: 33333352
[TBL] [Abstract][Full Text] [Related]
2. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
Mangalea MR; Duerkop BA
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
[TBL] [Abstract][Full Text] [Related]
3. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
[TBL] [Abstract][Full Text] [Related]
4. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
Fujiki J; Nakamura K; Nakamura T; Iwano H
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
[TBL] [Abstract][Full Text] [Related]
5. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
Torres-Barceló C
Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
[TBL] [Abstract][Full Text] [Related]
6. Use of bacteriophage to target bacterial surface structures required for virulence: a systematic search for antibiotic alternatives.
Orndorff PE
Curr Genet; 2016 Nov; 62(4):753-757. PubMed ID: 27113766
[TBL] [Abstract][Full Text] [Related]
7. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
Tagliaferri TL; Jansen M; Horz HP
Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
[TBL] [Abstract][Full Text] [Related]
8. Virulence-associated factors as targets for phage infection.
de Melo AG; Morency C; Moineau S
Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophages: potential treatment for bacterial infections.
Duckworth DH; Gulig PA
BioDrugs; 2002; 16(1):57-62. PubMed ID: 11909002
[TBL] [Abstract][Full Text] [Related]
10. Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.
Hauser AR; Mecsas J; Moir DT
Clin Infect Dis; 2016 Jul; 63(1):89-95. PubMed ID: 27025826
[TBL] [Abstract][Full Text] [Related]
11. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
12. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong T; Salabarria AC; Roach DR
Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Bacteriophage Therapy for Multi-Drug Resistant
Winzig F; Gandhi S; Lee A; Würstle S; Stanley GL; Capuano I; Neuringer I; Koff JL; Turner PE; Chan BK
Yale J Biol Med; 2022 Dec; 95(4):413-427. PubMed ID: 36568830
[TBL] [Abstract][Full Text] [Related]
14. [Customised infectiology - Phage therapy: from theory to clinical evidence].
Desgranges F; Bochud PY; Resch G
Rev Med Suisse; 2019 Apr; 15(646):771-775. PubMed ID: 30969489
[TBL] [Abstract][Full Text] [Related]
15. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
Łobocka M; Dąbrowska K; Górski A
BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
[TBL] [Abstract][Full Text] [Related]
16. European regulatory aspects of phage therapy: magistral phage preparations.
Verbeken G; Pirnay JP
Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
[TBL] [Abstract][Full Text] [Related]
17. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
[TBL] [Abstract][Full Text] [Related]
18. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
Maciejewska B; Olszak T; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
[TBL] [Abstract][Full Text] [Related]
19. Bacteriophage steering of
Ruest MK; Supina BSI; Dennis JJ
J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
Hasan M; Ahn J
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
